CD38 and Miyoshi myopathy: CAR-transduced iNKT cells were tested for their cytotoxic activity through the CAR-specific targeting of CD38 or BCMA expressed on multiple myeloma (MM) cell line UM9, as shown in Figure 2A. As expected, the UM9 cells were completely eradicated by the iNKT cells expressing the high affinity BCMA-CAR.